72494 Federal Register / Vol. 88, No. 202 / Friday, October 20, 2023 / Notices 

HRSA specifically requests comments 

on: (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–23257 Filed 10–19–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request; Information 

Collection Request Title: Voluntary 

Partner Surveys To Implement 

Executive Order 14058 in the Health 

Resources and Services 

Administration, OMB No. 0915–0212— 

Revision 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects of the Paperwork Reduction Act 

of 1995, HRSA announces plans to 

submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). Prior to submitting the ICR to 

OMB, HRSA seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on this ICR should be 

received no later than December 19, 

2023. 

ADDRESSES: Submit your comments to 

paperwork@hrsa.gov or mail the HRSA 

Information Collection Clearance 

Officer, Room 14N39, 5600 Fishers 

Lane, Rockville, MD 20857. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Joella Roland, the HRSA 

Information Collection Clearance 

Officer, at (301) 443–3983. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the ICR title 

for reference. 

Information Collection Request Title: 

Voluntary Partner Surveys to Implement 

Executive Order 14058 in the Health 

Resources and Services Administration, 

OMB No. 0915–0212—Revision. 

Abstract: The purpose of information 

collections under this generic umbrella 

ICR package is to conduct a limited 

number of partner surveys. If this 

generic ICR is approved, information on 

each individual partner survey 

conducted under this generic ICR will 

not be published separately in the 

Federal Register. Approval of this 

specific umbrella ICR would allow 

HRSA to continue to conduct voluntary 

customer surveys of its partners to 

assess strengths and weaknesses in 

program services and processes. A 

previous version of this ICR was done 

in response to Executive Order 12862, 

which called on the federal government 

to gather feedback from customers, set 

customer service standards, and 

measure performance against those 

standards. In December 2021, the White 

House issued Executive Order 14058, 

calling on the federal government to 

improve its service delivery to its 

customers and put people at the center 

of federal government activity. In 

accordance with this directive, HRSA is 

requesting approval of this generic 

umbrella ICR from OMB to conduct the 

partner surveys with a slight increase in 

the allotted burden hours so that HRSA 

can assess its performance from a larger 

swath of its partner population to help 

ensure that HRSA’s customer service 

delivery continues to improve, in 

accordance with the directive in 

Executive Order 14058. 

HRSA customer service feedback will 

continue to be gathered in the form of 

focus groups, in-class evaluation forms, 

mail surveys, and telephone surveys. 

Although HRSA cannot anticipate all 

the collections that will fall under this 

generic umbrella ICR, HRSA anticipates 

receiving OMB approval to include the 

following collections: 

• Surveys of HRSA grantees to 

determine satisfaction with grant 

processes or technical assistance 

provided by a HRSA contractor. Surveys 

may also be done to determine partner 

satisfaction with HRSA products or 

services. Surveys may be conducted by 

mail, telephone, or online. These 

surveys include the Division of 

Practitioner Data Bank Usability Survey 

generic fast track ICR, which helps 

identify strengths and weaknesses of the 

National Practitioner Data Bank 

customer service call center agents, and 

the HRSA Electronic Handbooks 

Customer Service Survey generic fast 

track ICR, which gathers public 

feedback about HRSA’s electronic 

handbooks. 

• Evaluation forms completed by 

providers who receive training from 

HRSA funding recipients, to measure 

satisfaction with the training 

experience. Evaluation forms may also 

be done after a conference or other 

training session with HRSA partners. 

Evaluation forms may be done hardcopy or online. One evaluation form 

generic fast track ICR that is expected to 

be included in this generic umbrella ICR 

is the National Ryan White Conference 

survey forms evaluating the National 

Ryan White Conference on HIV Care 

and Treatment and the Federal Cervical 

Cancer Collaborative Post-Roundtable 

Evaluation. This will help HRSA gain 

better understanding of participants’ 

experiences attending the Federal 

Cervical Cancer Collaborative 

Roundtable meetings. 

• Focus groups of HRSA grantees to 

learn more about their needs and 

concerns (e.g., professional 

development, technical assistance, and 

current or expected issues with program 

operations). Focus groups may also be 

conducted to learn more about how the 

people served by HRSA programs react 

to messaging related to HRSA program 

activities. Focus groups may be 

conducted online or in person. The 

HRSA focus group generic fast track ICR 

that is expected to be included in this 

generic umbrella ICR includes the 

HRSA Division of Transplantation 

Formative Evaluation Minority Organ 

Donation Outreach consisting of a group 

of online focus groups designed to 

gather feedback on several campaign 

concepts. 

Need and Proposed Use of the 

Information: Results of these surveys 

will be used to plan and redirect 

resources and efforts as needed to 

improve services and processes. Focus 

groups may also be used to gain partner 

input into the design of mail and 

telephone surveys. 

Likely Respondents: HRSA partners 

are typically state or local governments, 

health care facilities, health care 

consortia, health care providers, and 

researchers. HRSA partners may also 

include individuals served by HRSA 

programs and/or funding recipients. 

Participation in any collections under 

this clearance will be entirely voluntary, 

and the privacy of respondents will be 

preserved to the extent requested by 

participants and as permitted by law. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 202 / Friday, October 20, 2023 / Notices 72495 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. 

The number of respondents was 

revised based on information collections 

approved under the collection approved 

in 2021. HRSA anticipates that the total 

burden of collections under this generic 

package will be slightly greater than 

under the prior approval for two 

reasons. First, HRSA is incorporating 

the additional burden amount approved 

for this ICR via a 2023 non-substantive 

change memo. Second, HRSA is 

accounting for upcoming efforts to get 

public input from a larger swath of 

HRSA’s partners in compliance with 

Executive Order 14058. HRSA has 

decreased its estimate of the average 

burden per response for surveys to 

account for the increasing use of 

telephone and online surveys, rather 

than mail-in surveys, which are more 

time-consuming. The total annual 

burden hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden hours 

Evaluation forms .................................................................. 41,000 1 41,000 0.05 84,050,000 

Surveys (telephone, online) ................................................. 55,000 1 55,000 0.10 8,250 

Focus groups ....................................................................... 2,000 1 2,000 1.50 3,000 

Total .............................................................................. 98,000 ........................ 98,000 ........................ 84,061,250 

HRSA specifically requests comments 

on: (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–23130 Filed 10–19–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement (U01 

Clinical Trial Required). 

Date: November 14, 2023. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G45, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Vanitha S. Raman, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G45, Rockville, MD 

20852, 301–761–7949, vanitha.raman@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 17, 2023. 

David Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–23232 Filed 10–19–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Time-Sensitive 

Obesity Applications Review. 

Date: November 13, 2023. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

Division of Extramural Activities, NIDDK, 

National Institutes of Health, Room 7353, 

6707 Democracy Boulevard, Bethesda, MD 


ddrumheller on DSK120RN23PROD with NOTICES1